-The Economic Times Reports say that land acquisition for the proposed mega plant of Korean steel major Posco, off Paradip in coastal Orissa, has come to a grinding halt following incessant protests by men, women and children in the affected villages in the area, especially Dhinkia and Govindpur. It is now glaringly evident that a sorry lack of vision in garnering land for project implementation is stalling industry, new jobs and...

Ensuring food security to all is one of India’s top policy agendas today. Given a large mass of poverty in the country, it is not surprising and no one would perhaps disagree with the need to achieve this as soon as possible. But the varied policy instruments that can be used towards achieving this goal draw sharp differences among the stakeholders. What is food security? The World Food Summit of 1996...

It was the writer and activist Arundhati Roy who set foreign journalists in India busily chattering recently. In an interview with Stephen Moss in the Guardian, Ms Roy was discussing the Maoist and Adavasi “resistance” to encroachment on tribal lands. Mr Moss, asked her why, “we in the West don’t hear about these mini-wars?”. Ms Roy replied: “I have been told quite openly by several correspondents of international newspapers, that...

From the Middle East to Madagascar, high prices are spawning land grabs and ousting dictators. Welcome to the 21st-century food wars. In the United States, when world wheat prices rise by 75 percent, as they have over the last year, it means the difference between a $2 loaf of bread and a loaf costing maybe $2.10. If, however, you live in New Delhi, those skyrocketing costs really matter: A doubling in...

India’s FTAs pip generic drugs production Lot More For Less     * Generic drugs from India play a major role as antiretroviral drugs across the developing world     * A 2010 study says 80% of the medicines used by donor-funded programmes to treat people with HIV were sourced from India     * It’s cut down treatment costs drastically, from $10,000 to $80     * Stronger IP regimes may hamper production of generics *** The right of...